196 related articles for article (PubMed ID: 8840320)
21. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
[TBL] [Abstract][Full Text] [Related]
22. Molecular heterogeneity of amyloid beta2-microglobulin and modification with advanced glycation end products.
Mironova R; Niwa T
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(1):109-15. PubMed ID: 11482729
[TBL] [Abstract][Full Text] [Related]
23. Possible involvement of advanced glycation end-products in bone resorption.
Miyata T; Kawai R; Taketomi S; Sprague SM
Nephrol Dial Transplant; 1996; 11 Suppl 5():54-7. PubMed ID: 9044308
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of beta 2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament.
Morita H; Shinzato T; Cai Z; Horiuchi S; Maeda K
Nephron; 1996; 73(1):117-8. PubMed ID: 8742979
[No Abstract] [Full Text] [Related]
26. Beta-2-microglobulin amyloidosis and renal bone disease.
Drüeke TB
Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of dialysis-related amyloidosis in diabetic patients. Diabetes Amyloid Study Group.
Lehnert H; Jacob C; Marzoll I; Schmidt-Gayk H; Stein G; Ritz E
Nephrol Dial Transplant; 1996 Oct; 11(10):2004-7. PubMed ID: 8918714
[TBL] [Abstract][Full Text] [Related]
28. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
29. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
[TBL] [Abstract][Full Text] [Related]
30. Dialysis arthropathy, amyloidosis and beta-2 microglobulin.
Cameron JS
Pediatr Nephrol; 1987 Apr; 1(2):224-9. PubMed ID: 3153281
[No Abstract] [Full Text] [Related]
31. Beta-2-microglobulin amyloidosis in long-term dialysis patients.
Stone WJ; Hakim RM
Am J Nephrol; 1989; 9(3):177-83. PubMed ID: 2667360
[No Abstract] [Full Text] [Related]
32. The pathogenesis of dialysis-related amyloidosis: what's new?
Zhang X; Hou F
Chin Med J (Engl); 1999 Dec; 112(12):1059-62. PubMed ID: 11721438
[No Abstract] [Full Text] [Related]
33. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
34. Beta 2-microglobulin, amyloidosis, and dialysis.
Acchiardo S
Int J Artif Organs; 1988 Jul; 11(4):229-31. PubMed ID: 3045017
[No Abstract] [Full Text] [Related]
35. Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments.
Floege J; Wilks MF; Granolleras C; Shaldon S; Koch KM
Contrib Nephrol; 1989; 74():120-6. PubMed ID: 2702128
[No Abstract] [Full Text] [Related]
36. The pathogenesis of beta(2)-microglobulin-induced bone lesions in dialysis-related amyloidosis.
Tran M; Rutecki GW; Sprague SM
Semin Dial; 2001; 14(2):131-3. PubMed ID: 11264782
[TBL] [Abstract][Full Text] [Related]
37. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
[No Abstract] [Full Text] [Related]
38. Beta 2-microglobulin-derived amyloidosis: clinical use of scintigraphy and insights into its pathogenesis.
Floege J; Schäffer J; Ehlerding G
Nephrol Dial Transplant; 1993; 8(9):792-3. PubMed ID: 8255509
[No Abstract] [Full Text] [Related]
39. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
40. Dialysis amyloidosis: beta-2-microglobulin in the context of other amyloidogenic proteins.
Gorevic PD; Munoz P
Blood Purif; 1988; 6(2):132-44. PubMed ID: 3293617
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
